Hypocretin/orexin deficiency decreases cocaine abuse liability

Area of Science:

• Neuroscience
• Behavioral Pharmacology

Background:

• Hypocretin/orexin signaling is crucial for arousal, stress, and reward.
• Previous research primarily used pharmacological blockers to study its role in drug reward.

Purpose of the Study:

• To investigate the effects of innate hypocretin/orexin deficiency on cocaine-related behaviors.
• To evaluate cocaine sensitization, place preference, and self-administration in deficient mice.

Main Methods:

• Compared cocaine responses in hypocretin/orexin-deficient (KO), heterozygous (HET), and wildtype (WT) mice.
• Assessed behavioral sensitization, conditioned place preference, and self-administration.
• Administered cocaine (15 mg/kg) for sensitization and place preference, and 0.5-1.5 mg/kg/infusion for self-administration.

Main Results:

• All mice showed similar acute responses to cocaine.
• Hcrt KO mice exhibited reduced cocaine-seeking behaviors after abstinence and decreased incubation craving.
• Hypocretin/orexin deficiency did not impair attention but led to a hypoactive phenotype.

Conclusions:

• Innate hypocretin/orexin deficiency moderately affects cocaine reward but significantly reduces long-term affective dependence.
• These mice display resilience to cocaine addiction, with blunted intake and reduced relapse potential.
• Hypocretin/orexin signaling is a potential therapeutic target for reducing cocaine addiction vulnerability.